{"id":"https://openalex.org/W155504689","doi":null,"title":"Dual Dopaminergic Actions Contribute to Discriminative Stimulus Functions of Orally Administered Modafinil in Rats","display_name":"Dual Dopaminergic Actions Contribute to Discriminative Stimulus Functions of Orally Administered Modafinil in Rats","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W155504689","mag":"155504689"},"language":"en","primary_location":{"id":"mag:155504689","doi":null,"is_oa":false,"landing_page_url":"https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=1051&context=grad_research_posters","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051653501","display_name":"Amanda J. Quisenberry","orcid":"https://orcid.org/0000-0003-0108-8473","observed_orcids":["https://orcid.org/0000-0003-0108-8473"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda J. Quisenberry","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0108-8473","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039615945","display_name":"Erin E. Watkins","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erin E. Watkins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102895132","display_name":"Eric L. Harvey","orcid":"https://orcid.org/0000-0003-2190-7675","observed_orcids":["https://orcid.org/0000-0003-2190-7675"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric L. Harvey","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2190-7675","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5082772810","display_name":"Jennifer L. Walters","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer L. Walters","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00985195,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10985","display_name":"Sleep and Wakefulness Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/modafinil","display_name":"modafinil","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-discrimination","display_name":"drug discrimination","score":0.6439999938011169},{"id":"https://openalex.org/keywords/cocaine","display_name":"cocaine","score":0.6370000243186951},{"id":"https://openalex.org/keywords/dopamine-transporter","display_name":"dopamine transporter","score":0.7599999904632568},{"id":"https://openalex.org/keywords/stimulant-dependence","display_name":"stimulant use disorder","score":0.746999979019165},{"id":"https://openalex.org/keywords/mdma","display_name":"MDMA","score":0.4300000071525574},{"id":"https://openalex.org/keywords/discriminative-stimuli","display_name":"discriminative stimulus","score":0.5360000133514404},{"id":"https://openalex.org/keywords/dopamine-agonists","display_name":"dopamine agonists","score":0.32600000500679016},{"id":"https://openalex.org/keywords/stimulant-misuse","display_name":"stimulant abuse","score":0.44600000977516174}],"concepts":[{"id":"https://openalex.org/C2780714222","wikidata":"https://www.wikidata.org/wiki/Q410441","display_name":"Modafinil","level":2,"score":0.9683738946914673},{"id":"https://openalex.org/C2780876324","wikidata":"https://www.wikidata.org/wiki/Q69488","display_name":"MDMA","level":2,"score":0.8710784912109375},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.6969788074493408},{"id":"https://openalex.org/C2779494582","wikidata":"https://www.wikidata.org/wiki/Q189561","display_name":"Narcolepsy","level":3,"score":0.6020206809043884},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5763636231422424},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5430282354354858},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.5412030816078186},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.5253148078918457},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.49680259823799133},{"id":"https://openalex.org/C2776145449","wikidata":"https://www.wikidata.org/wiki/Q1706418","display_name":"Dextroamphetamine","level":4,"score":0.465446799993515},{"id":"https://openalex.org/C2776755682","wikidata":"https://www.wikidata.org/wiki/Q2271947","display_name":"Dopamine transporter","level":4,"score":0.4643585681915283},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39249739050865173},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.24303609132766724}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:155504689","doi":null,"is_oa":false,"landing_page_url":"https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=1051&context=grad_research_posters","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W138931730","https://openalex.org/W1538619854","https://openalex.org/W1966136869","https://openalex.org/W1977916644","https://openalex.org/W1983250142","https://openalex.org/W2033437417","https://openalex.org/W2067161638","https://openalex.org/W2068302359","https://openalex.org/W2109987251","https://openalex.org/W2122011624","https://openalex.org/W2140991283","https://openalex.org/W2162998760","https://openalex.org/W2314953511"],"related_works":["https://openalex.org/W1657635040","https://openalex.org/W67390951","https://openalex.org/W2135695308","https://openalex.org/W1977916644","https://openalex.org/W2169331715","https://openalex.org/W2026700397","https://openalex.org/W2033437417","https://openalex.org/W106811370","https://openalex.org/W2735868454","https://openalex.org/W2008994373"],"abstract_inverted_index":{"Figure":[0],"1.":[1],"During":[2],"the":[3,23,31,40,65,141,155,193,253,262,274,292,329,338,348],"CPP":[4],"test,":[5],"animals":[6],"that":[7,250],"had":[8],"received":[9],"cocaine":[10,214,233,259],"(10":[11],"or":[12,232],"20":[13],"mg/kg)":[14],"during":[15],"drug":[16,197,333],"conditioning":[17],"trials":[18],"spent":[19],"more":[20],"time":[21],"in":[22,30,39,102,131,163,207,223,301],"cocaine-paired":[24],"side.":[25],"These":[26],"effects":[27,266,300,340],"were":[28],"enhanced":[29,252],"Cocaine":[32,41,45],"20/MDMA":[33,46],"3.0":[34,43],"treatment":[35,48,66],"group,":[36],"and":[37,44,74,100,116,147,219,258,269,291,343,345],"reduced":[38],"10/MDMA":[42],"1.5":[47],"groups.":[49],"\uf0d8":[50,78,122,182,243,272,308],"Modafinil":[51,199],"(Provigil\u00ae)":[52],"is":[53,185,306],"a":[54,61,135,166,186,319],"mild":[55],"CNS":[56],"stimulant":[57],"currently":[58],"marketed":[59],"as":[60,279,318],"wakepromoting":[62],"agent":[63],"for":[64,264,284],"of":[67,127,137,168,196,230,255,277,294,298,326,341],"excessive":[68],"daytime":[69],"sleepiness":[70],"associated":[71],"with":[72,303],"narcolepsy":[73],"other":[75,304],"sleep":[76],"disorders.":[77],"It":[79],"has":[80,129,160,200],"also":[81,248],"been":[82,161,201],"investigated":[83],"to":[84,133,191,203,210,226,322,336,346,352],"treat":[85],"psychostimulant":[86,285],"dependence":[87],"(Dackis":[88],"et":[89,93,106,113,119,171,175,179,216,235,239,245,288],"al.,":[90,94,107,114,120,172,176,180,217,236,240,289],"2005;":[91],"Anderson":[92],"2009;":[95],"Reichel":[96],"&":[97,150],"See,":[98],"2010)":[99,218],"fatigue":[101],"Parkinson\u2019s":[103],"disease":[104],"(Hoal":[105],"2002),":[108],"amyotrophic":[109],"lateral":[110],"sclerosis":[111],"(Carter":[112],"2005),":[115],"dementia":[117],"(Howcroft":[118],"2002).":[121],"Research":[123],"investigating":[124],"modafinil\u2019s":[125,299,353],"mechanism":[126,325],"action":[128],"resulted":[130],"evidence":[132],"support":[134],"variety":[136,167],"neurotransmitter":[138],"systems":[139],"including":[140],"catecholamines,":[142],"serotonin,":[143],"glutamate,":[144],"GABA,":[145],"orexin,":[146],"histamine":[148],"(Minzenberg":[149],"Carter,":[151],"2008).":[152],"In":[153],"particular,":[154],"dopamine":[156],"transporter":[157],"system":[158],"(DAT)":[159],"implicated":[162],"studies":[164],"utilizing":[165,316],"assays":[169],"(Wisor":[170],"2001;":[173],"Dopheide":[174,244],"2007;":[177,237],"Zolkowska":[178],"2009).":[181],"Drug":[183],"discrimination":[184,254,334],"behavioral":[187],"assay":[188],"commonly":[189],"employed":[190,332],"characterize":[192],"pharmacological":[194,349],"mechanisms":[195],"action.":[198,327],"shown":[202],"produce":[204],"full":[205],"substitution":[206,222],"rats":[208,224],"trained":[209,225],"discriminate":[211,227],"10":[212],"mg/kg":[213],"(Paterson":[215],"significant":[220],"partial":[221],"low":[228,256],"doses":[229],"d-amphetamine":[231,257,344],"(Dopheide":[234],"Quisenberry":[238],"unpublished":[241],"findings).":[242],"al.":[246],"(2007)":[247],"reported":[249],"modafinil":[251,268,278,317,342],"doses,":[260],"implicating":[261],"potential":[263],"additive":[265],"between":[267],"psychomotor":[270],"stimulants.":[271],"Considering":[273],"possible":[275],"effectiveness":[276],"an":[280],"agonist":[281],"replacement":[282],"therapy":[283],"abuse":[286],"(Shearer":[287],"2009)":[290],"prevalence":[293],"polysubstance":[295],"abuse,":[296],"evaluation":[297],"combination":[302],"psychostimulants":[305],"warranted.":[307],"To":[309],"date,":[310],"there":[311],"are":[312],"no":[313],"published":[314],"reports":[315],"training":[320],"stimulus":[321,355],"investigate":[323],"its":[324],"Therefore,":[328],"current":[330],"study":[331],"procedures":[335],"evaluate":[337],"combined":[339],"determine":[347],"actions":[350],"contributing":[351],"discriminative":[354],"effects.":[356]},"counts_by_year":[],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2016-06-24T00:00:00"}